– Arun is the Founder and CEO at APL. He founded Aten Biotech in 2009, a plant biotechnology company based in Bangalore. Through this venture, he has been responsible for supplying more than 200 patented varieties of ornamental crops to ~ 20 countries across the globe. As part of the management team at Aten Biotech, the team has grown to more than 60 employees. Arun holds an MBA from the Royal Melbourne Institute of Technology (Australia), and a Bachelor of Science degree in Chemistry from Christ University (India).
– Aditya is the Founder and CSO at APL. He has worked extensively on the development of self-assembled polymers, polymeric prodrugs and nanoparticles for gene and drug delivery. He has co-authored >15 peer-reviewed publications and filed international patents in the areas of nucleic acid delivery, Niemann-Pick Type C therapeutics, and MRI contrast agents. He has been a recipient of the Chemical Biology Scholarship at the University of Leeds and the Purdue Research Foundation Fellowship at Purdue University. He was also awarded the prestigious H. C. Brown Award for Outstanding Organic Research at Purdue University in June 2012. Aditya has a Ph.D. in Bioorganic Chemistry from Purdue University (USA), MS in Chemical Biology from Leeds University (UK), and B.Sc in Chemistry from Christ University (India).
– Srinivasan is the Founder and Director at APL. He is currently serving as the CEO of Porus Labs, a chemical manufacturing conglomerate serving customers across India, US, and Europe. Srinivasan has over 10 years of experience in varied aspects of business including technology transfer, SCM, Business Development and Finance. After completing his M.S., he briefly worked with Ohm Laboratories, a subsidiary of Ranbaxy at New Jersey prior to joining the business in 2003. Srinivasan has an MS in Pharmaceutics from Northeastern University (USA), and B.Pharm from BITS Pilani (India).
– Tom is the CBO at APL. Tom was formerly the CEO at Mucosis, a leading vaccine development company, having joined from Novavax (NASDAQ) where as Vice President of Strategy he developed and executed a regional partnership strategy with deals in India, Mexico, and South Korea. Prior to Novavax, Tom has previously served as an executive-level strategic consultant in a number of industries including biotech, and held various senior-level positions with a number of world-class organizations such as Comcast, Microsoft, and Schlumberger. Tom holds an M.B.A. from The Wharton Business School and a Bachelor of Science degree in Computer Science from Arcadia University (USA).